However, PD-1 expression on CD8+ T cells is upregulated in patients with HCC and activation of PD-1 is an important mechanism by which tumor cells can inhibit anti-tumor immune responses mediated by CD8+ T cells [10, 11]. This evidence concerns the gene CD8A and hepatocellular carcinoma.